A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depression.
Adolescent
Adult
Aged
Australia
/ epidemiology
Depressive Disorder, Major
/ epidemiology
Female
Humans
Male
Medical History Taking
/ methods
Middle Aged
New Zealand
/ epidemiology
Online Systems
Patient Education as Topic
/ methods
Patient Health Questionnaire
Primary Health Care
/ methods
Therapy, Computer-Assisted
/ methods
Young Adult
Bipolar disorder
Family history
Major depressive disorder
Online intervention
Psycho-education
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
17 01 2019
17 01 2019
Historique:
received:
14
12
2017
accepted:
19
12
2018
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
4
12
2019
Statut:
epublish
Résumé
People with a family history of major depressive disorder (MDD) or bipolar disorder (BD) report specific psychoeducational needs that are unmet by existing online interventions. This trial aimed to test whether an interactive website for people at familial risk for depression (intervention) would improve intention to adopt, or actual adoption of, depression prevention strategies (primary outcome) and a range of secondary outcome measures. In this cluster randomised trial, primary care practises were randomised to either provide the link to the intervention or the control website. Primary health care attendees were invited by letter to opt into this study if they had at least one first-degree relative with MDD or BD and were asked to complete online questionnaires at baseline and 2-week follow-up. Twenty general practices were a randomized, and 202 eligible patients completed both questionnaires. Thirty-nine (19.3%) of participants were male and 163 (80.7%) female. At follow-up, compared to controls, the intervention group: (i) were more likely to intend to undergo, or to have actually undergone, psychological therapies (OR = 5.83, 95% CI: 1.58-21.47, p = .008); (ii) had better knowledge of depression risk factors and prevention strategies (mean difference = 0.47, 95% CI: 0.05-0.88, p = .029); and (iii) were more likely to accurately estimate their lifetime risk of developing BD (mean difference = 11.2, 95% CI: -16.52- -5.73, p < .001). There were no statistically significant between-group differences in change from baseline to follow up for any of the remaining outcome measures (Patient Health Questionnaire, Perceived Devaluation-Discrimination Questionnaire and Perceived Risk of Developing MDD). The opt-in nature of the study may have led to participation bias, e.g. underrepresentation of males, and hence may limit generalisability to the broader population at familial risk for depression. This is the first website internationally focusing specifically on informational needs of those at familial risk of depression. Our interactive website can play an important role in improving the outcomes of individuals at familial risk for depression. Testing the intervention in other settings (e.g. psychology, psychiatry, genetic counselling) appears warranted. The study was prospectively registered with the Australian and New Zealand Clinical Trials Group (Registration no: ACTRN12613000402741 ).
Sections du résumé
BACKGROUND
People with a family history of major depressive disorder (MDD) or bipolar disorder (BD) report specific psychoeducational needs that are unmet by existing online interventions. This trial aimed to test whether an interactive website for people at familial risk for depression (intervention) would improve intention to adopt, or actual adoption of, depression prevention strategies (primary outcome) and a range of secondary outcome measures.
METHODS
In this cluster randomised trial, primary care practises were randomised to either provide the link to the intervention or the control website. Primary health care attendees were invited by letter to opt into this study if they had at least one first-degree relative with MDD or BD and were asked to complete online questionnaires at baseline and 2-week follow-up.
RESULTS
Twenty general practices were a randomized, and 202 eligible patients completed both questionnaires. Thirty-nine (19.3%) of participants were male and 163 (80.7%) female. At follow-up, compared to controls, the intervention group: (i) were more likely to intend to undergo, or to have actually undergone, psychological therapies (OR = 5.83, 95% CI: 1.58-21.47, p = .008); (ii) had better knowledge of depression risk factors and prevention strategies (mean difference = 0.47, 95% CI: 0.05-0.88, p = .029); and (iii) were more likely to accurately estimate their lifetime risk of developing BD (mean difference = 11.2, 95% CI: -16.52- -5.73, p < .001). There were no statistically significant between-group differences in change from baseline to follow up for any of the remaining outcome measures (Patient Health Questionnaire, Perceived Devaluation-Discrimination Questionnaire and Perceived Risk of Developing MDD).
CONCLUSION
The opt-in nature of the study may have led to participation bias, e.g. underrepresentation of males, and hence may limit generalisability to the broader population at familial risk for depression. This is the first website internationally focusing specifically on informational needs of those at familial risk of depression. Our interactive website can play an important role in improving the outcomes of individuals at familial risk for depression. Testing the intervention in other settings (e.g. psychology, psychiatry, genetic counselling) appears warranted.
TRIAL REGISTRATION
The study was prospectively registered with the Australian and New Zealand Clinical Trials Group (Registration no: ACTRN12613000402741 ).
Identifiants
pubmed: 30654777
doi: 10.1186/s12888-018-1994-2
pii: 10.1186/s12888-018-1994-2
pmc: PMC6337794
doi:
Banques de données
ANZCTR
['ACTRN12613000402741']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
29Références
Arch Gen Psychiatry. 2003 May;60(5):497-502
pubmed: 12742871
Am J Med Genet A. 2009 Mar;149A(3):364-71
pubmed: 19215049
J Med Ethics. 2006 Aug;32(8):473-7
pubmed: 16877628
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
JAMA. 2009 Jun 3;301(21):2215-24
pubmed: 19491183
Arch Gen Psychiatry. 2000 Jul;57(7):675-82
pubmed: 10891038
JAMA. 2012 Mar 14;307(10):1033-4
pubmed: 22416097
J Affect Disord. 2004 Jan;78(1):49-55
pubmed: 14672796
BMC Med Res Methodol. 2004 Dec 22;4(1):30
pubmed: 15613248
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Br J Psychiatry. 2008 Feb;192(2):130-4
pubmed: 18245031
BMC Psychiatry. 2013 Dec 01;13:325
pubmed: 24289740
Psychol Med. 2011 Aug;41(8):1605-13
pubmed: 21159212
J Affect Disord. 2012 Feb;136(3):320-7
pubmed: 22177740
Am J Psychiatry. 2004 Oct;161(10):1814-21
pubmed: 15465978
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):926-8
pubmed: 16958030
BMC Med. 2009 Dec 16;7:79
pubmed: 20015347
J Med Internet Res. 2002 Jan-Mar;4(1):e3
pubmed: 11956035
Br J Psychiatry. 2004 Oct;185:342-9
pubmed: 15458995
Psychol Med. 2007 Nov;37(11):1601-11
pubmed: 17537283
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004691
pubmed: 16856055
J Abnorm Psychol. 2004 Feb;113(1):155-9
pubmed: 14992668
Psychol Med. 2006 Dec;36(12):1737-46
pubmed: 16938144
Am J Psychiatry. 2008 Oct;165(10):1272-80
pubmed: 18765483
Schizophr Bull. 2014 Jan;40(1):88-99
pubmed: 23104866
Arch Gen Psychiatry. 1999 Jan;56(1):39-44
pubmed: 9892254
J Clin Psychiatry. 2016 Feb;77(2):e190-8
pubmed: 26930535
J Genet Couns. 2014 Oct;23(5):785-95
pubmed: 24407933
J Nutr Health Aging. 2013;17(5):441-5
pubmed: 23636545
Arch Gen Psychiatry. 2001 Dec;58(12):1127-34
pubmed: 11735841
Genet Med. 2009 Apr;11(4):265-78
pubmed: 19265718
J Genet Couns. 2017 Apr;26(2):312-321
pubmed: 27688164
Aust N Z J Psychiatry. 2006 Jan;40(1):3-5
pubmed: 16403031
Int Rev Psychiatry. 2007 Dec;19(6):655-70
pubmed: 18092243
Br J Psychiatry. 2018 Mar;212(3):169-174
pubmed: 29436312
Cochrane Database Syst Rev. 2004;(1):CD003380
pubmed: 14974014
Psychiatr Serv. 2012 Oct;63(10):963-73
pubmed: 23032675
JAMA Psychiatry. 2013 Nov;70(11):1161-70
pubmed: 24005242
J Affect Disord. 2014 Apr;158:37-47
pubmed: 24655763
Bipolar Disord. 2006 Jun;8(3):271-4
pubmed: 16696829
Psychiatry Clin Neurosci. 2006 Dec;60(6):662-8
pubmed: 17109699
Am Psychol. 2005 Jul-Aug;60(5):410-21
pubmed: 16045394
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Med Hypotheses. 2007;69(6):1316-9
pubmed: 17499448
Psychol Med. 2012 Mar;42(3):509-19
pubmed: 21849093
Clin Genet. 2015 Mar;87(3):218-24
pubmed: 24773225
PLoS One. 2011;6(6):e21274
pubmed: 21712998
Biol Psychiatry. 2002 Sep 15;52(6):457-77
pubmed: 12361664